Trouillet-Assant Sophie

Head of a Joint Unit Hospices Civils de Lyon-Lyon1 University - bioMérieux, focused on infectious diseases and viral infections

[Casanova Lab @casanova_lab]

HERE IS WHY:
Autoantibodies against Cytokines — From Infection to Inflammation | New England Journal of Medicine https://t.co/kjxgcj5tfR

[Cell @CellCellPress]

Now online! Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections https://t.co/hFXctgq6Oh

[Journal of Human Immunity @jhumimmunity]

David Bussy, Sophie Trouillet-Assant and colleagues @UnivLyon1 @inserm present a case of increased within-host viral diversity linked to impaired type I interferon response during #COVID19: https://t.co/Mcwl4eoUPB

#Infections #AutoAntibodies #SARSCoV2

[Trouillet-Assant Sophie @TrouilletAssant]

2- 🧠 It’s time to embrace innovative strategies for viral diagnostics !
🎥 Learn more in a video on our website dedicated to the ANR Chair program _ https://t.co/UlTtjIJoeg

[Trouillet-Assant Sophie @TrouilletAssant]

1- 🚀 Excited to announce our latest publication on the performance of host-based markers to enhance the diagnosis of viral respiratory infections
📄 https://t.co/4B0gUfMMH8
@agenceANRS @biomerieux @CHUdeLyon @CIRI_Lyon @VirPath @Lyonbiopole @AgenceRecherche @UnivLyon1

[Trouillet-Assant Sophie @TrouilletAssant]

@MasatoOgishi @RockefellerUniv @casanova_lab @StanfordMed Congrats Masato!

[Trouillet-Assant Sophie @TrouilletAssant]

A new undeniable proof of the importance of investigating the presence of auto-antibodies to type I Interferon

[Casanova Lab @casanova_lab]

1/ 📢 📰 In @JExpMed, we report that about 10% of children with life-threatening #COVID19 harbor auto-antibodies to type I IFNs. (https://t.co/1i0vtvxEzX)

[Trouillet-Assant Sophie @TrouilletAssant]

@casanova_lab @CellCellPress Bravo jean Laurent and co!
Well done!

[Trouillet-Assant Sophie @TrouilletAssant]

Very proud of this excellent team!

[Belot Alexandre @AlexandreBelot]

Thrilled to share our paper in @NEJM on pre-COVID and SARS-CoV-2 negative MIS-C. This condition predates the pandemic but was incredibly rare and often misdiagnosed as Kawasaki Disease Shock Syndrome or Toxic Shock Syndrome without identified bacteria https://t.co/ADSsYrVazj 🧵

[Casanova Lab @casanova_lab]

1/ 🔉Our lab is looking for two energetic and enthusiastic #postdocs 👩‍🔬🧑‍🔬 to study the causes and consequences of auto-Abs to type I IFNs (https://t.co/LKopzuccFT). If you are interested, please write to [email protected] 📧 .

[Trouillet-Assant Sophie @TrouilletAssant]

Very excited to start our new project REVIDA granted by Agence Nationale de la Recherche via Chaire Industrielle program.
@CIRI_Lyon; @CHUdeLyon ; @UnivLyon1 ; @biomerieux; @AgenceRecherche
https://t.co/SkNkD2sIac

[Trouillet-Assant Sophie @TrouilletAssant]

Very fascinating results! Congrats @casanova_lab @anne_puel and Tom! https://t.co/gWvwNf4mUX

[Casanova Lab @casanova_lab]

1/ We are excited to report in @Nature the discovery that human inborn errors of the alternative NF-κB pathway-dependent immunity underlie the development of auto-Abs neutralizing type I IFNs (https://t.co/TFUOnBPIFi).